Clinical trial NCT05866575 - References

Major Depressive Disorder — Prediction of the Therapeutic Response in Depression Based on Neuro-computational Modeling Assessment of Motivation

Citation(s)

•   Bauer M, Pfennig A, Severus E, Whybrow PC, Angst J, Moller HJ; World Federation of Societies of Biological Psychiatry
  Task Force on Unipolar Depressive Disorders. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders. World J Biol Psychiatry. 2013 Jul;14(5):334-85. doi: 10.3109/15622975.2013.804195. Epub 2013 Jul 3.
•   Berwian IM, Wenzel JG, Collins AGE, Seifritz E, Stephan KE, Walter H, Huys QJM
  Computational Mechanisms of Effort and Reward Decisions in Patients With Depression and Their Association With Relapse After Antidepressant Discontinuation. JAMA Psychiatry. 2020 May 1;77(5):513-522. doi: 10.1001/jamapsychiatry.2019.4971.
•   Brown S, Rittenbach K, Cheung S, McKean G, MacMaster FP, Clement F
  Current and Common Definitions of Treatment-Resistant Depression: Findings from a Systematic Review and Qualitative Interviews. Can J Psychiatry. 2019 Jun;64(6):380-387. doi: 10.1177/0706743719828965. Epub 2019 Feb 14.
•   Chen G, Bian H, Jiang D, Cui M, Ji S, Liu M, Lang X, Zhuo C
  Pseudo-continuous arterial spin labeling imaging of cerebral blood perfusion asymmetry in drug-naive patients with first-episode major depression. Biomed Rep. 2016 Dec;5(6):675-680. doi: 10.3892/br.2016.796. Epub 2016 Oct 31.
•   Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, Egger M, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JPA, Geddes JR
  Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018 Apr 7;391(10128):1357-1366. doi: 10.1016/S0140-6736(17)32802-7. Epub 2018 Feb 21.
•   Clery-Melin ML, Schmidt L, Lafargue G, Baup N, Fossati P, Pessiglione M
  Why don't you try harder? An investigation of effort production in major depression. PLoS One. 2011;6(8):e23178. doi: 10.1371/journal.pone.0023178. Epub 2011 Aug 10.
•   Colle R, Dupong I, Colliot O, Deflesselle E, Hardy P, Falissard B, Ducreux D, Chupin M, Corruble E
  Smaller hippocampal volumes predict lower antidepressant response/remission rates in depressed patients: A meta-analysis. World J Biol Psychiatry. 2018 Aug;19(5):360-367. doi: 10.1080/15622975.2016.1208840. Epub 2016 Aug 15.
•   Cooper CM, Chin Fatt CR, Liu P, Grannemann BD, Carmody T, Almeida JRC, Deckersbach T, Fava M, Kurian BT, Malchow AL, McGrath PJ, McInnis M, Oquendo MA, Parsey RV, Bartlett E, Weissman M, Phillips ML, Lu H, Trivedi MH
  Discovery and replication of cerebral blood flow differences in major depressive disorder. Mol Psychiatry. 2020 Jul;25(7):1500-1510. doi: 10.1038/s41380-019-0464-7. Epub 2019 Aug 6.
•   Corlett PR, Fletcher PC
  Computational psychiatry: a Rosetta Stone linking the brain to mental illness. Lancet Psychiatry. 2014 Oct;1(5):399-402. doi: 10.1016/S2215-0366(14)70298-6. Epub 2014 Aug 12. No abstract available.
•   Culpepper L
  Escitalopram: A New SSRI for the Treatment of Depression in Primary Care. Prim Care Companion J Clin Psychiatry. 2002 Dec;4(6):209-214. doi: 10.4088/pcc.v04n0601.
•   Daunizeau J, Adam V, Rigoux L
  VBA: a probabilistic treatment of nonlinear models for neurobiological and behavioural data. PLoS Comput Biol. 2014 Jan;10(1):e1003441. doi: 10.1371/journal.pcbi.1003441. Epub 2014 Jan 23.
•   Development of the World Health Organization WHOQOL-BREF quality of life assessment
  The WHOQOL Group. Psychol Med. 1998 May;28(3):551-8. doi: 10.1017/s0033291798006667.
•   Felice D, Guilloux JP, Pehrson A, Li Y, Mendez-David I, Gardier AM, Sanchez C, David DJ
  Vortioxetine Improves Context Discrimination in Mice Through a Neurogenesis Independent Mechanism. Front Pharmacol. 2018 Mar 12;9:204. doi: 10.3389/fphar.2018.00204. eCollection 2018.
•   Fervaha G, Foussias G, Agid O, Remington G
  Motivational and neurocognitive deficits are central to the prediction of longitudinal functional outcome in schizophrenia. Acta Psychiatr Scand. 2014 Oct;130(4):290-9. doi: 10.1111/acps.12289. Epub 2014 May 22.
•   Fervaha G, Foussias G, Takeuchi H, Agid O, Remington G
  Motivational deficits in major depressive disorder: Cross-sectional and longitudinal relationships with functional impairment and subjective well-being. Compr Psychiatry. 2016 Apr;66:31-8. doi: 10.1016/j.comppsych.2015.12.004. Epub 2015 Dec 18.
•   Friston K, Mattout J, Trujillo-Barreto N, Ashburner J, Penny W
  Variational free energy and the Laplace approximation. Neuroimage. 2007 Jan 1;34(1):220-34. doi: 10.1016/j.neuroimage.2006.08.035. Epub 2006 Oct 20.
•   Harrison NA, Voon V, Cercignani M, Cooper EA, Pessiglione M, Critchley HD
  A Neurocomputational Account of How Inflammation Enhances Sensitivity to Punishments Versus Rewards. Biol Psychiatry. 2016 Jul 1;80(1):73-81. doi: 10.1016/j.biopsych.2015.07.018. Epub 2015 Aug 1.
•   Hartwig V, Giovannetti G, Vanello N, Lombardi M, Landini L, Simi S
  Biological effects and safety in magnetic resonance imaging: a review. Int J Environ Res Public Health. 2009 Jun;6(6):1778-98. doi: 10.3390/ijerph6061778. Epub 2009 Jun 10.
•   Hasler G
  Can the neuroeconomics revolution revolutionize psychiatry? Neurosci Biobehav Rev. 2012 Jan;36(1):64-78. doi: 10.1016/j.neubiorev.2011.04.011. Epub 2011 Apr 29.
•   Hayakawa YK, Sasaki H, Takao H, Hayashi N, Kunimatsu A, Ohtomo K, Aoki S
  Depressive symptoms and neuroanatomical structures in community-dwelling women: A combined voxel-based morphometry and diffusion tensor imaging study with tract-based spatial statistics. Neuroimage Clin. 2014 Mar 12;4:481-7. doi: 10.1016/j.nicl.2014.03.002. eCollection 2014.
•   Huys QJ, Maia TV, Frank MJ
  Computational psychiatry as a bridge from neuroscience to clinical applications. Nat Neurosci. 2016 Mar;19(3):404-13. doi: 10.1038/nn.4238.
•   Kaichi Y, Okada G, Takamura M, Toki S, Akiyama Y, Higaki T, Matsubara Y, Okamoto Y, Yamawaki S, Awai K
  Changes in the regional cerebral blood flow detected by arterial spin labeling after 6-week escitalopram treatment for major depressive disorder. J Affect Disord. 2016 Apr;194:135-43. doi: 10.1016/j.jad.2015.12.062. Epub 2016 Jan 21.
•   Keks N, Hope J, Keogh S
  Switching and stopping antidepressants. Aust Prescr. 2016 Jun;39(3):76-83. doi: 10.18773/austprescr.2016.039. Epub 2016 Jun 1.
•   Koesters M, Ostuzzi G, Guaiana G, Breilmann J, Barbui C
  Vortioxetine for depression in adults. Cochrane Database Syst Rev. 2017 Jul 5;7(7):CD011520. doi: 10.1002/14651858.CD011520.pub2.
•   Kojima M, Matsui K, Mizui T
  BDNF pro-peptide: physiological mechanisms and implications for depression. Cell Tissue Res. 2019 Jul;377(1):73-79. doi: 10.1007/s00441-019-03034-6. Epub 2019 May 10.
•   Lam RW, Kennedy SH, Grigoriadis S, McIntyre RS, Milev R, Ramasubbu R, Parikh SV, Patten SB, Ravindran AV; Canadian Network for Mood and Anxiety Treatments (CANMAT)
  Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy. J Affect Disord. 2009 Oct;117 Suppl 1:S26-43. doi: 10.1016/j.jad.2009.06.041. Epub 2009 Aug 11.
•   Le Heron C, Plant O, Manohar S, Ang YS, Jackson M, Lennox G, Hu MT, Husain M
  Distinct effects of apathy and dopamine on effort-based decision-making in Parkinson's disease. Brain. 2018 May 1;141(5):1455-1469. doi: 10.1093/brain/awy110.
•   Lebreton M, Jorge S, Michel V, Thirion B, Pessiglione M
  An automatic valuation system in the human brain: evidence from functional neuroimaging. Neuron. 2009 Nov 12;64(3):431-9. doi: 10.1016/j.neuron.2009.09.040.
•   Mauras T, Masson M, Fossati P, Pessiglione M
  Incentive Sensitivity as a Behavioral Marker of Clinical Remission From Major Depressive Episode. J Clin Psychiatry. 2016 Jun;77(6):e697-703. doi: 10.4088/JCP.15m09995.
•   Meyniel F, Goodwin GM, Deakin JW, Klinge C, MacFadyen C, Milligan H, Mullings E, Pessiglione M, Gaillard R
  A specific role for serotonin in overcoming effort cost. Elife. 2016 Nov 8;5:e17282. doi: 10.7554/eLife.17282.
•   Montague PR, Dolan RJ, Friston KJ, Dayan P
  Computational psychiatry. Trends Cogn Sci. 2012 Jan;16(1):72-80. doi: 10.1016/j.tics.2011.11.018. Epub 2011 Dec 14. Erratum In: Trends Cogn Sci. 2012 May;16(5):306.
•   Montgomery SA, Asberg M
  A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979 Apr;134:382-9. doi: 10.1192/bjp.134.4.382.
•   Nutt D, Demyttenaere K, Janka Z, Aarre T, Bourin M, Canonico PL, Carrasco JL, Stahl S
  The other face of depression, reduced positive affect: the role of catecholamines in causation and cure. J Psychopharmacol. 2007 Jul;21(5):461-71. doi: 10.1177/0269881106069938. Epub 2006 Oct 18.
•   O'Doherty JP, Hampton A, Kim H
  Model-based fMRI and its application to reward learning and decision making. Ann N Y Acad Sci. 2007 May;1104:35-53. doi: 10.1196/annals.1390.022. Epub 2007 Apr 7.
•   Ogyu K, Kubo K, Noda Y, Iwata Y, Tsugawa S, Omura Y, Wada M, Tarumi R, Plitman E, Moriguchi S, Miyazaki T, Uchida H, Graff-Guerrero A, Mimura M, Nakajima S
  Kynurenine pathway in depression: A systematic review and meta-analysis. Neurosci Biobehav Rev. 2018 Jul;90:16-25. doi: 10.1016/j.neubiorev.2018.03.023. Epub 2018 Mar 30.
•   Osimo EF, Pillinger T, Rodriguez IM, Khandaker GM, Pariante CM, Howes OD
  Inflammatory markers in depression: A meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls. Brain Behav Immun. 2020 Jul;87:901-909. doi: 10.1016/j.bbi.2020.02.010. Epub 2020 Feb 27.
•   Ota M, Noda T, Sato N, Hattori K, Teraishi T, Hori H, Nagashima A, Shimoji K, Higuchi T, Kunugi H
  Characteristic distributions of regional cerebral blood flow changes in major depressive disorder patients: a pseudo-continuous arterial spin labeling (pCASL) study. J Affect Disord. 2014 Aug;165:59-63. doi: 10.1016/j.jad.2014.04.032. Epub 2014 Apr 21.
•   Palminteri S, Justo D, Jauffret C, Pavlicek B, Dauta A, Delmaire C, Czernecki V, Karachi C, Capelle L, Durr A, Pessiglione M
  Critical roles for anterior insula and dorsal striatum in punishment-based avoidance learning. Neuron. 2012 Dec 6;76(5):998-1009. doi: 10.1016/j.neuron.2012.10.017.
•   Pessiglione M, Delgado MR
  The good, the bad and the brain: Neural correlates of appetitive and aversive values underlying decision making. Curr Opin Behav Sci. 2015 Oct;5:78-84. doi: 10.1016/j.cobeha.2015.08.006. Epub 2015 Aug 24.
•   Pessiglione M, Schmidt L, Draganski B, Kalisch R, Lau H, Dolan RJ, Frith CD
  How the brain translates money into force: a neuroimaging study of subliminal motivation. Science. 2007 May 11;316(5826):904-6. doi: 10.1126/science.1140459. Epub 2007 Apr 12.
•   Pessiglione M, Vinckier F, Bouret S, Daunizeau J, Le Bouc R
  Why not try harder? Computational approach to motivation deficits in neuro-psychiatric diseases. Brain. 2018 Mar 1;141(3):629-650. doi: 10.1093/brain/awx278.
•   Ruckbeil MV, Hilgers RD, Heussen N
  Randomization in survival studies: An evaluation method that takes into account selection and chronological bias. PLoS One. 2019 Jun 3;14(6):e0217946. doi: 10.1371/journal.pone.0217946. eCollection 2019.
•   Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R, Thase ME, Kocsis JH, Keller MB
  The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003 Sep 1;54(5):573-83. doi: 10.1016/s0006-3223(02)01866-8. Erratum In: Biol Psychiatry. 2003 Sep 1;54(5):585.
•   Sanchez C, Asin KE, Artigas F
  Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data. Pharmacol Ther. 2015 Jan;145:43-57. doi: 10.1016/j.pharmthera.2014.07.001. Epub 2014 Jul 9.
•   Schmidt L, Lebreton M, Clery-Melin ML, Daunizeau J, Pessiglione M
  Neural mechanisms underlying motivation of mental versus physical effort. PLoS Biol. 2012 Feb;10(2):e1001266. doi: 10.1371/journal.pbio.1001266. Epub 2012 Feb 21.
•   Sheehan DV, Harnett-Sheehan K, Spann ME, Thompson HF, Prakash A
  Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale. Int Clin Psychopharmacol. 2011 Mar;26(2):75-83. doi: 10.1097/YIC.0b013e328341bb5f.
•   Skvortsova V, Palminteri S, Pessiglione M
  Learning to minimize efforts versus maximizing rewards: computational principles and neural correlates. J Neurosci. 2014 Nov 19;34(47):15621-30. doi: 10.1523/JNEUROSCI.1350-14.2014.
•   Snaith RP, Hamilton M, Morley S, Humayan A, Hargreaves D, Trigwell P
  A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale. Br J Psychiatry. 1995 Jul;167(1):99-103. doi: 10.1192/bjp.167.1.99.
•   Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leiguarda R, Robinson RG
  Reliability, validity, and clinical correlates of apathy in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 1992 Spring;4(2):134-9. doi: 10.1176/jnp.4.2.134.
•   Stephan KE, Bach DR, Fletcher PC, Flint J, Frank MJ, Friston KJ, Heinz A, Huys QJM, Owen MJ, Binder EB, Dayan P, Johnstone EC, Meyer-Lindenberg A, Montague PR, Schnyder U, Wang XJ, Breakspear M
  Charting the landscape of priority problems in psychiatry, part 1: classification and diagnosis. Lancet Psychiatry. 2016 Jan;3(1):77-83. doi: 10.1016/S2215-0366(15)00361-2. Epub 2015 Nov 11.
•   Stephan KE, Binder EB, Breakspear M, Dayan P, Johnstone EC, Meyer-Lindenberg A, Schnyder U, Wang XJ, Bach DR, Fletcher PC, Flint J, Frank MJ, Heinz A, Huys QJM, Montague PR, Owen MJ, Friston KJ
  Charting the landscape of priority problems in psychiatry, part 2: pathogenesis and aetiology. Lancet Psychiatry. 2016 Jan;3(1):84-90. doi: 10.1016/S2215-0366(15)00360-0. Epub 2015 Nov 11.
•   Stephan KE, Schlagenhauf F, Huys QJM, Raman S, Aponte EA, Brodersen KH, Rigoux L, Moran RJ, Daunizeau J, Dolan RJ, Friston KJ, Heinz A
  Computational neuroimaging strategies for single patient predictions. Neuroimage. 2017 Jan 15;145(Pt B):180-199. doi: 10.1016/j.neuroimage.2016.06.038. Epub 2016 Jun 22.
•   Treadway MT, Buckholtz JW, Cowan RL, Woodward ND, Li R, Ansari MS, Baldwin RM, Schwartzman AN, Kessler RM, Zald DH
  Dopaminergic mechanisms of individual differences in human effort-based decision-making. J Neurosci. 2012 May 2;32(18):6170-6. doi: 10.1523/JNEUROSCI.6459-11.2012.
•   Uher R, Perlis RH, Henigsberg N, Zobel A, Rietschel M, Mors O, Hauser J, Dernovsek MZ, Souery D, Bajs M, Maier W, Aitchison KJ, Farmer A, McGuffin P
  Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms. Psychol Med. 2012 May;42(5):967-80. doi: 10.1017/S0033291711001905. Epub 2011 Sep 20.
•   Verdonk F, Petit AC, Abdel-Ahad P, Vinckier F, Jouvion G, de Maricourt P, De Medeiros GF, Danckaert A, Van Steenwinckel J, Blatzer M, Maignan A, Langeron O, Sharshar T, Callebert J, Launay JM, Chretien F, Gaillard R
  Microglial production of quinolinic acid as a target and a biomarker of the antidepressant effect of ketamine. Brain Behav Immun. 2019 Oct;81:361-373. doi: 10.1016/j.bbi.2019.06.033. Epub 2019 Jun 28.
•   Vinckier F, Rigoux L, Oudiette D, Pessiglione M
  Neuro-computational account of how mood fluctuations arise and affect decision making. Nat Commun. 2018 Apr 26;9(1):1708. doi: 10.1038/s41467-018-03774-z.
•   Wardle MC, Treadway MT, Mayo LM, Zald DH, de Wit H
  Amping up effort: effects of d-amphetamine on human effort-based decision-making. J Neurosci. 2011 Nov 16;31(46):16597-602. doi: 10.1523/JNEUROSCI.4387-11.2011.

Prediction of the Therapeutic Response in Depression Based on an Early Neuro-computational Modeling Assessment of Motivation

Details for clinical trial NCT05866575